AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Which Crypto Should Newbies Buy First
Which Crypto Should Newbies Buy First guides you to practical, beginner-friendly first purchases.
27,491 articles
Delaying Social Security to 70: A 70-Year-Old with $600,000
A retiree with a $600,000 IRA defers claiming Social Security to age 70 to secure the 8% yearly boost. The strategy, ...
Desperate Federal Investigators Weigh DNA Genealogy Tool
Federal investigators are weighing the use of DNA genealogy databases to pursue leads in the Nancy Guthrie disappeara...
Best Aerospace Defense Stocks to Watch Right Now in 2026
Global security priorities and rising defense budgets spotlight the best aerospace defense stocks. Here’s a timely lo...
Why Amprius Technologies Stock Surged Today for Investors
A niche battery company moved sharply higher as growth signals and product milestones drew investor attention. This a...
Solar Shares Shine: SolarEdge Leads a Broad Solar Rally
SolarEdge spearheads a broad solar stock bounce as bond yields retreat, with Enphase Energy and Sunrun posting solid ...
Arms Race Shifting Again—These Picks and Shovels Shine
Nvidia signals a wave of AI data-center demand, but investors are eyeing Broadcom and ASML as durable infrastructure ...
JPMorgan’s Dividend Leaders ETF Faces Low Yield Reality
JPMorgan’s Dividend Leaders ETF shows a surprising income mismatch, posting a 1.59% yield while Treasuries offer more...
Social Security’s 2027 COLA Outlook Hits Retirees Hard
The 2027 cost-of-living adjustment is projected to be about 2.8%, continuing a pattern of modest bumps that often lag...
AI Agent Aims to Reshape Builders Site Screening Now
A newly launched AI agent is set to overhaul how builders screen land and gauge deal risk, potentially speeding loans...
Palantir Insiders Selling Shares Spur Defense Stock Bets
Insider trading patterns at Palantir raise questions about the stock's growth path as defense sector stocks attract c...
Patient Investors Win with 4,000% 5,000% Over Five Years
Long-term holders in NVDA, AMD, and LLY are posting outsized gains as AI and GLP-1 drug momentum persists. Traders wh...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status